Exelixis
EXEL
#1554
Rank
โ‚ฌ12.31 B
Marketcap
49,72ย โ‚ฌ
Share price
0.65%
Change (1 day)
51.29%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company